Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT02939417 Not yet recruiting - Clinical trials for Retention & Fracture of Emax Laminate Veneers

One Year Clinical Evaluation of E.Max Laminate Veneers With and Without Using Grape Seed Extract as a Natural Collagen Cross-linking Agent Before Bonding

Start date: November 2016
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the clinical performance of E-max veneers cemented with and without using grape seed extract before bonding.

NCT ID: NCT02937935 Not yet recruiting - Clinical trials for Acute Kidney Injury With Cirrhosis

On Demand Versus Protocol-guided Renal Replacement Therapy for Management of Stage 3 Acute Kidney Injury in Patients With Cirrhosis

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Intervention: All patients at presentation would be assessed for the underlying cause of and will be managed by removal of all precipitants(careful review of medications, diuretics, nephrotoxic drugs,vasodilators or non-steroidal anti-inflammatory drugs). The second step would be to consider plasma volume expansion in patients with hypovolemia (the choice of fluid could either be a crystalloid or albumin or even blood as indicated) along with identification and early treatment of bacterial infections. Along with this patients with a differential diagnosis of HRS-AKI would be given terlipressin ( or noradrenaline/octreotide midodrine in case of contraindication to terlipressin). Patients with a clinical diagnosis of ATN would be randomized to the on-demand versus protocol-guided dialysis groups. Further, patients with urine output of less than 0.5ml/kg/hour for 4-6 hours despite adequate fluid resuscitation and vasoconstrictors would also be subjected to randomization. 1. In the on-demand group patients would get dialysis only when patient fulfills absolute criteria requiring dialysis such as metabolic acidosis with ph<7.2, hyperkalemia, refractory fluid overload (non-responsive to diuretics) or oliguria with urine output of less than 0.5ml/kg for more than 24-48 hours from the time of randomization 2. In the protocol guided group patients all patients would be considered for dialysis within 6 hours of randomization After randomization patients would receive dialysis as three sessions per week of at least 4 h with a blood flow >200 mL/min and a dialysate flow >500 mL/min in intermittent group and as 20-25 mL/kg/h of effluent, by filtration and/or diffusion in continuous form until recovery of renal functions

NCT ID: NCT02936661 Not yet recruiting - Clinical trials for Postpartum Hemorrhage, Cesarean Section

Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section

Start date: April 2017
Phase: Phase 4
Study type: Interventional

It is a multicenter randomized, double-blind and placebo-controlled trial. Totally 6500 women to delivery by cesarean section will be recruited in this study. In addition to routinely oxytocin, the women in study group will receive TXA 1 g in 2 minutes after they delivered their babies, and those in control group will receive placebo. The incidence of postpartum hemorrhage, the amount of bleeding, as well as the side effects will be observed.

NCT ID: NCT02934906 Not yet recruiting - Clinical trials for Neonatal Alloimmune Thrombocytopenia

Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

Start date: January 2017
Phase: N/A
Study type: Observational

This clinical study aims to investigate the anti-HPA antibodies caused neonatal alloimmune thrombocytopenia in Chinese pregnant women. The survey and data collect will help form an appropriate clinical screening procedure

NCT ID: NCT02934048 Not yet recruiting - Helicobacter Pylori Clinical Trials

Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Strongly evidence supports that H. pylori eradication is an effective approach to reduce the incidence of those pathologies. However, due to the increasing resistance rates to antibiotics, failures of H. pylori eradication get more and more common. Thus, rescue therapy for persistent H. pylori infection is becoming a grand challenge the investigators have to face.

NCT ID: NCT02933775 Not yet recruiting - Clinical trials for CD19 Positive Malignant B-cell Leukemia and Lymphoma

CD19-redirected Autologous Cells (CAR-CD19 T Cells)

Start date: October 2016
Phase: Phase 1
Study type: Interventional

This study is designed for determining the safety and relative engraftment levels of the redirected autologous T cells transduced with the anti-CD19 lentiviral vector in patients with CD19-positive B cell leukemia and malignant lymphoma.

NCT ID: NCT02933229 Not yet recruiting - Helicobacter Pylori Clinical Trials

The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Helicobacter pylori (H. pylori) infection, affecting an estimated 50% of the global population, is a main cause of chronic gastritis, peptic ulcers and gastric cancer. By causing progressive damage to the stomach and may eventually result in gastric atrophy, H. pylori infection has been demonstrated to be responsible for more than 95% of gastric malignancies

NCT ID: NCT02932735 Not yet recruiting - Clinical trials for Probe-based Confocal Laser Endomicroscopy

The Efficacy of Probe-based Confocal Laser Endomicroscopy in Staging OLGIM

Start date: October 2016
Phase: N/A
Study type: Observational

Gastric intestinal metaplasia (GIM) is an important premalignant lesion for gastric cancer. Precisely surveillance of patients with GIM may result in early detection and improved prognosis. Though important, it is not necessary to recommend surveillance endoscopy for all patients with GIM, since the progression rate to gastric cancer within 10 years is only 1.8% in those patients.

NCT ID: NCT02931006 Not yet recruiting - Clinical trials for Gonadotrophin and Sex Hormone Changes

Influence of Bovine Milk Consumption on Hormonal Profile in Males

Start date: January 2017
Phase: N/A
Study type: Interventional

50 men will be recruited to this study. Participants will be asked to ingest commercially available bovine milk. Hormonal profile will be analyzed before and after consumption.

NCT ID: NCT02930616 Not yet recruiting - Clinical trials for Gastric Intestinal Metaplasia

A Comparison of pCLE Based Targeted Biopsy and WLE Based Standard Biopsy in Staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM): A Randomized,Cross-over Study

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Gastric intestinal metaplasia (GIM) is an important premalignant lesion for gastric cancer. Precisely surveillance of patients with GIM may result in early detection and improved prognosis. Though important, it is not necessary to recommend surveillance endoscopy for all patients with GIM, since the progression rate to gastric cancer within 10 years is only 1.8% in those patients.